Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study

Author:

Iles S M,Gollins S W,Susnerwala S,Haylock B,Myint S,Biswas A,Swindell R,Levine E

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference51 articles.

1. Alonso V, Lambea J, Salud A, Valencia J, Mira M, Polo S, Escudero P, Sierra E, Monzon A (2007) Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal carcinoma: a phase II trial. J Clin Oncol 25 (18S): Abstract 4044

2. Alonso V, Salud A, Escudero P, Valencia J, Mira M, Ruiz de Lobera A, Lambea J, Grandez F, Tres A, Anton A (2004) Preoperative chemoradiation with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma. J Clin Oncol 22 (14S): ASCO Annual Meeting: Abstract 3607

3. Aschele C, Friso ML, Pucciarelli S, Lonardi S, Sartor L, Fabris G, Urso ED, Del Bianco P, Sotti G, Lise M, Monfardini S (2005) A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 16: 1140–1146

4. Avallone A, Delrio P, Guida C, Tatangelo F, Petrillo A, Marone P, Cascini LG, Morrica B, Lastoria S, Parisi V, Budillon A, Comella P (2006) Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study. Br J Cancer 94: 1809–1815. e-pub 30 May 2006, doi:10.1038/sj.bjc.6603195

5. Carraro S, Roca EL, Cartelli C, Rafailovici L, Castillo Odena S, Wasserman E, Gualdrini U, Huertas E, Barugel M, Ballarino G, Rodriguez MC, Masciangioli G (2002) Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiation Oncol Biol Physics 54: 397–402

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3